MXPA04001230A - Uso de inhibidores de il-18 en desordenes de hipersensibilidad. - Google Patents
Uso de inhibidores de il-18 en desordenes de hipersensibilidad.Info
- Publication number
- MXPA04001230A MXPA04001230A MXPA04001230A MXPA04001230A MXPA04001230A MX PA04001230 A MXPA04001230 A MX PA04001230A MX PA04001230 A MXPA04001230 A MX PA04001230A MX PA04001230 A MXPA04001230 A MX PA04001230A MX PA04001230 A MXPA04001230 A MX PA04001230A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- hypersensitivity disorders
- hypersensitivity
- disorders
- medicament
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 2
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000009610 hypersensitivity Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000005951 type IV hypersensitivity Effects 0.000 abstract 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invencion se refiere al uso de inhibidores de IL-18 en la preparacion de un medicamento para tratamiento y/o prevencion de desordenes de hipersensibilidad, y en particular de hipersensibilidad de tipo retardada.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01118811 | 2001-08-10 | ||
| EP02100735 | 2002-06-20 | ||
| PCT/EP2002/008591 WO2003013577A2 (en) | 2001-08-10 | 2002-08-01 | Use of il-18 inhibitors in hypersensitivity disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04001230A true MXPA04001230A (es) | 2004-05-27 |
Family
ID=26076673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04001230A MXPA04001230A (es) | 2001-08-10 | 2002-08-01 | Uso de inhibidores de il-18 en desordenes de hipersensibilidad. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20040247598A1 (es) |
| EP (1) | EP1423138B1 (es) |
| JP (1) | JP4301942B2 (es) |
| KR (1) | KR20040030948A (es) |
| CN (1) | CN100500210C (es) |
| AR (1) | AR035274A1 (es) |
| AU (1) | AU2002331376B2 (es) |
| BR (1) | BRPI0211827B8 (es) |
| CA (1) | CA2456247C (es) |
| CY (1) | CY1116137T1 (es) |
| DK (1) | DK1423138T3 (es) |
| EA (1) | EA006745B1 (es) |
| ES (1) | ES2533253T3 (es) |
| HK (1) | HK1069780A1 (es) |
| HR (1) | HRP20040071B1 (es) |
| HU (1) | HU230377B1 (es) |
| IL (2) | IL160230A0 (es) |
| ME (1) | ME00547B (es) |
| MX (1) | MXPA04001230A (es) |
| NO (1) | NO335688B1 (es) |
| PL (1) | PL227130B1 (es) |
| PT (1) | PT1423138E (es) |
| RS (1) | RS52224B (es) |
| SI (1) | SI1423138T1 (es) |
| UA (1) | UA78516C2 (es) |
| WO (1) | WO2003013577A2 (es) |
| ZA (1) | ZA200400442B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006003927A1 (ja) * | 2004-06-30 | 2006-01-12 | Atsuo Sekiyama | 非炎症性ストレス応答の指標剤およびその利用 |
| JP5199073B2 (ja) | 2005-06-03 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | 組換えｉｌ−１８結合タンパク質の生産 |
| CA2610804C (en) | 2005-06-10 | 2013-11-19 | Ares Trading S.A. | Process for the purification of il-18 binding protein |
| PE20080262A1 (es) | 2006-05-25 | 2008-04-30 | Glaxo Group Ltd | Anticuerpo humanizado contra interleuquina-18 |
| JP5937015B2 (ja) * | 2010-12-16 | 2016-06-22 | 株式会社明治 | 遅延型過敏症軽減剤 |
| WO2024261470A1 (en) * | 2023-06-20 | 2024-12-26 | Apollo Ap43 Limited | Anti-il-18 antibody therapy for treating atopic dermatitis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922737A (en) * | 1996-02-21 | 1999-07-13 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases |
| US6087116A (en) * | 1997-03-12 | 2000-07-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18 (IL-18) receptor polypeptides and their uses |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| WO1999046248A1 (en) * | 1998-03-09 | 1999-09-16 | Vertex Pharmaceuticals Incorporated | 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| KR100537558B1 (ko) * | 1998-09-01 | 2005-12-19 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | 인터류킨-18 결합 단백질 |
| WO2000071719A1 (en) * | 1999-05-20 | 2000-11-30 | Hyseq, Inc. | Interleukin-1 hy2 materials and methods |
| WO2002032374A2 (en) * | 2000-10-18 | 2002-04-25 | Immunex Corporation | Methods for treating il-18 mediated disorders |
-
2002
- 2002-01-08 UA UA2004031727A patent/UA78516C2/uk unknown
- 2002-08-01 WO PCT/EP2002/008591 patent/WO2003013577A2/en active IP Right Grant
- 2002-08-01 US US10/486,612 patent/US20040247598A1/en not_active Abandoned
- 2002-08-01 HU HU0401323A patent/HU230377B1/hu unknown
- 2002-08-01 IL IL16023002A patent/IL160230A0/xx unknown
- 2002-08-01 JP JP2003518583A patent/JP4301942B2/ja not_active Expired - Lifetime
- 2002-08-01 CA CA2456247A patent/CA2456247C/en not_active Expired - Lifetime
- 2002-08-01 PL PL368231A patent/PL227130B1/pl unknown
- 2002-08-01 AU AU2002331376A patent/AU2002331376B2/en not_active Expired
- 2002-08-01 PT PT2767299T patent/PT1423138E/pt unknown
- 2002-08-01 DK DK02767299.7T patent/DK1423138T3/en active
- 2002-08-01 MX MXPA04001230A patent/MXPA04001230A/es active IP Right Grant
- 2002-08-01 EA EA200400296A patent/EA006745B1/ru not_active IP Right Cessation
- 2002-08-01 ES ES02767299.7T patent/ES2533253T3/es not_active Expired - Lifetime
- 2002-08-01 RS YU11904A patent/RS52224B/sr unknown
- 2002-08-01 EP EP02767299.7A patent/EP1423138B1/en not_active Expired - Lifetime
- 2002-08-01 KR KR10-2004-7001962A patent/KR20040030948A/ko active Search and Examination
- 2002-08-01 CN CNB028201515A patent/CN100500210C/zh not_active Expired - Lifetime
- 2002-08-01 SI SI200231054T patent/SI1423138T1/sl unknown
- 2002-08-01 BR BR0211827A patent/BRPI0211827B8/pt not_active IP Right Cessation
- 2002-08-01 ME MEP-2008-641A patent/ME00547B/me unknown
- 2002-08-09 AR ARP020103018A patent/AR035274A1/es unknown
-
2004
- 2004-01-21 ZA ZA2004/00442A patent/ZA200400442B/en unknown
- 2004-01-23 HR HRP20040071AA patent/HRP20040071B1/hr not_active IP Right Cessation
- 2004-01-27 NO NO20040370A patent/NO335688B1/no not_active IP Right Cessation
- 2004-02-05 IL IL160230A patent/IL160230A/en active IP Right Grant
-
2005
- 2005-04-22 HK HK05103457.5A patent/HK1069780A1/xx not_active IP Right Cessation
-
2015
- 2015-03-23 CY CY20151100290T patent/CY1116137T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04003666A (es) | Uso de flibanserina para tratamiento de trastornos sexuales. | |
| IL164211A (en) | Il-18 inhibitors in peripheral vascular diseases of the extremities | |
| WO2004041269A3 (en) | New use for pharmaceutical composition | |
| IL158181A0 (en) | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity | |
| YU82602A (sh) | Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze | |
| WO2003088748A8 (en) | Use of heme oxygenase-1 and products of heme degradation | |
| HK1081861A1 (en) | New synergistic combination comprising roflumilast and formoterol | |
| HK1082923A1 (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency | |
| CY1116137T1 (el) | Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας | |
| AU7862401A (en) | Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer | |
| YU57803A (sh) | Upotreba inhibitora il-18 za lečenje i/ili prevenciju srčanih oboljenja | |
| HK1068106A1 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
| HUP0401633A2 (hu) | Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására | |
| EP1303300A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS | |
| BG108451A (en) | Use of il-18 inhibitors for treating or preventing cns injuries | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| HU0200980D0 (es) | ||
| SI1408966T1 (sl) | Sinergistične farmacevtske kombinacije za preprečevanje ali zdravljenje diabetesa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights | ||
| FG | Grant or registration |